Annexon (ANNX) Preferred Dividend Payments (2019 - 2020)
Annexon (ANNX) posted quarterly Preferred Dividend Payments of $145000.0 for Q3 2020, down 48.4% year-over-year from $281000.0 in Q4 2019, and down 97.7% quarter-over-quarter from $6.3 million in Q2 2020.
Annexon (ANNX) Preferred Dividend Payments (2019 - 2020) Analysis & Trends
Annexon's Preferred Dividend Payments history runs 2 years deep, the most recent figure standing at $145000.0 for Q3 2020.
- In Q3 2020, Preferred Dividend Payments fell 48.4% year-over-year to $145000.0; the TTM figure through Dec 2020 stood at $6.7 million (changed N/A YoY), while the FY2020 annual figure was $705000.0, down 35.62% from the prior year.
- Preferred Dividend Payments for Q3 2020 stood at $145000.0, down from $6.3 million in the prior quarter.
- The five-year high for Preferred Dividend Payments was $6.3 million in Q2 2020, with the low at $145000.0 in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Annexon | 1.00 Bn | 1.00 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 145,000.00 |
| Jun 30, 2020 | 6.30 Mn |
| Mar 31, 2020 | 279,000.00 |
| Dec 31, 2019 | 280,000.00 |
| Sep 30, 2019 | 281,000.00 |
| Jun 30, 2019 | 272,000.00 |